Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease
about
Potential Role of Epigenetic Mechanism in Manganese Induced NeurotoxicityVanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicityHistone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson diseaseActivation of GSK-3β and caspase-3 occurs in Nigral dopamine neurons during the development of apoptosis activated by a striatal injection of 6-hydroxydopamineProtein kinase D1 (PKD1) phosphorylation promotes dopaminergic neuronal survival during 6-OHDA-induced oxidative stress.Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's DiseaseRe-Cloning the N27 Dopamine Cell Line to Improve a Cell Culture Model of Parkinson's Disease.N-Acetyl Cysteine Protects against Methamphetamine-Induced Dopaminergic Neurodegeneration via Modulation of Redox Status and Autophagy in Dopaminergic Cells.Alterations in mitochondrial dynamics induced by tebufenpyrad and pyridaben in a dopaminergic neuronal cell culture model.Molecular cloning, epigenetic regulation, and functional characterization of Prkd1 gene promoter in dopaminergic cell culture models of Parkinson's disease.Role of proteolytic activation of protein kinase Cδ in the pathogenesis of prion disease.C-terminal binding proteins are essential pro-survival factors that undergo caspase-dependent downregulation during neuronal apoptosis.Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration.α-Tocopherol at Nanomolar Concentration Protects Cortical Neurons against Oxidative Stress.Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.Novel siRNA delivery strategy: a new "strand" in CNS translational medicine?Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors.Alterations in bioenergetic function induced by Parkinson's disease mimetic compounds: lack of correlation with superoxide generation.Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.Silver nanoparticles reduce brain inflammation and related neurotoxicity through induction of H2S-synthesizing enzymes.Dopaminergic neurotoxins induce cell death by attenuating NF-κB-mediated regulation of TRPC1 expression and autophagy.Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo.Organophosphate pesticide chlorpyrifos impairs STAT1 signaling to induce dopaminergic neurotoxicity: Implications for mitochondria mediated oxidative stress signaling events.
P2860
Q26744563-5D7067A1-317A-4164-9427-425028256DF6Q28388187-A085F114-B670-4A32-9595-C23B3DED94F6Q34683308-D790534D-ECB7-4F38-A140-73E4653E8E89Q34936413-8B313EA9-7413-48F5-92DC-2A5BD3D4AABCQ35164624-7265DD78-0AB8-46E7-B755-C8D3E3A63DBFQ35829484-D8F9D457-9296-409C-A6DF-C4BB75576330Q36101048-7D457C7F-0477-4E63-8522-29E002B3DC8BQ36302371-9F7C6C09-E6DC-47FA-B110-2DDAFB441A92Q36422034-C72292C4-92BF-4294-9C3A-0DF808B8AB7BQ36821650-B0C44710-2552-4603-9EE0-222FBDFB8667Q37184038-9193EB40-82CF-40A0-8E16-BEF0153A603EQ37216918-3A67D65B-D733-4BBA-90FF-E05137E2C1DAQ37329938-F9908052-E8A9-4678-BDF9-B2540C4C88ADQ37631713-E4C23A67-C44A-4DD8-B8EE-464CE393474CQ38021940-162329D8-FA0E-4D0F-9B10-D885AFBFC201Q38091009-220D80A1-554D-4B4B-BB17-0A465B7DCE88Q39153958-8A242B63-BF23-4D71-B843-B4058EB3296BQ39329410-1E5B6584-57EC-4C4E-9FD2-CCA1D62D3897Q39356354-A1980D32-1142-4F15-8EF4-E179FA99F161Q41844051-A843FEFA-72E3-4D09-9F72-4A4F8EB63170Q49911674-04D622CC-54E2-4A36-8836-94379EEE421EQ52579561-2908B22A-604E-4BE3-A12C-4FB749C56D57Q54977318-AF2972A0-3407-4A17-985D-311C3EDECBAF
P2860
Dopaminergic neurotoxicant 6-OHDA induces oxidative damage through proteolytic activation of PKCδ in cell culture and animal models of Parkinson's disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dopaminergic neurotoxicant 6-O ...... models of Parkinson's disease
@ast
Dopaminergic neurotoxicant 6-O ...... models of Parkinson's disease
@en
type
label
Dopaminergic neurotoxicant 6-O ...... models of Parkinson's disease
@ast
Dopaminergic neurotoxicant 6-O ...... models of Parkinson's disease
@en
prefLabel
Dopaminergic neurotoxicant 6-O ...... models of Parkinson's disease
@ast
Dopaminergic neurotoxicant 6-O ...... models of Parkinson's disease
@en
P2093
P2860
P921
P1476
Dopaminergic neurotoxicant 6-O ...... models of Parkinson's disease
@en
P2093
Anumantha Kanthasamy
Arthi Kanthasamy
Calivarathan Latchoumycandane
Huajun Jin
Vellareddy Anantharam
P2860
P304
P356
10.1016/J.TAAP.2011.07.021
P577
2011-08-06T00:00:00Z